What's Going On With Heartbeam (BEAT) Stock?
What's Going On With Heartbeam (BEAT) Stock?
Heartbeam Inc (NASDAQ:BEAT) shares are trading higher by 3.5% to $2.35 Tuesday, pulling back following the session high of $2.70. The earlier move higher came despite a lack of company-specific news for the session.
週二，Heartbeam Inc（納斯達克股票代碼：BEAT）股價上漲3.5％，至2.35美元，在盤中高點2.70美元后回落。儘管該交易日缺乏公司具體消息，但早些時候還是出現了走高。
The company last week said it secured two new patents from the United States Patent and Trademark Office for its vectorelectrocardiography (VECG) technology, bringing its total to 14 issued US patents and 4 international patents.
該公司上週表示，其矢量心電圖（VECG）技術獲得了美國專利和商標局的兩項新專利，使其已頒發的美國專利和4項國際專利總數達到14項。
The VECG technology collects 3D signals of the heart and converts them into a 12-lead ECG. These patents reinforce HeartBeam's commitment to transforming cardiac care by enabling personalized insights through portable, patient-friendly devices such as credit-card sized systems, extended wear patches or watches.
VECG 技術收集心臟的 3D 信號，並將其轉換爲 12 導聯心電圖。這些專利通過便攜式、便於患者的設備（例如信用卡大小的系統、長效磨損貼片或手錶）提供個性化見解，從而強化了HeartBeam對改變心臟護理的承諾。
The first patent focuses on a mobile three-lead cardiac monitoring device and method for automated diagnostics, aiding in the detection of heart attacks. The second patent covers HeartBeam's wrist-based ECG system, which combines continuous monitoring with the ability to take a high sensitivity 12-lead ECG.
第一項專利側重於一種移動式三導心臟監測設備和自動診斷方法，有助於檢測心臟病發作。第二項專利涵蓋了HeartBeam的手腕式心電圖系統，該系統將持續監測與拍攝高靈敏度12導聯心電圖的能力相結合。
Is BEAT A Good Stock To Buy?
BEAT 是一隻值得買入的好股票嗎？
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like HeartBeam's page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
投資者在決定股票是否值得買入時可以做出一些決定。除了可以在Benzinga的報價頁面（例如HeartBeam的頁面）上找到的估值指標和價格走勢外，還有一些因素，例如公司是否每季度支付股息或購買大部分股票。
These are known as capital allocation programs. HeartBeam (NASDAQ:BEAT) does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
這些被稱爲資本分配計劃。HeartBeam（納斯達克股票代碼：BEAT）不支付股息，但顯然有幾種方法可以向股東返還價值。您可以隨時在Benzinga的股息日曆中搜索下一家即將派發股息的公司，並確定持有該公司股份可以獲得什麼樣的收益率。
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on HeartBeam will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
回購計劃顯然是不同的，而且變化很大。公司可以批准回購計劃，並在回購獲得批准的時間內酌情購買股票。瀏覽HeartBeam的最新消息通常可以得出該公司最近是否批准了回購計劃。回購計劃通常作爲股價的支撐，作爲需求的支撐。
According to data from Benzinga Pro, BEAT has a 52-week high of $3.74 and a 52-week low of $1.06.
根據Benzinga Pro的數據，BEAT的52周高點爲3.74美元，52周低點爲1.06美元。